Effect of Dry Eye Treatment on Corneal Astigmatism Measurements
Effect of Dry Eye and Ocular Surface Treatment on Agreement and Repeatability of Corneal Astigmatism Measurements Among Three Devices
This prospective single-center study evaluates the effect of dry eye disease and short-term ocular surface treatment on the agreement and repeatability of corneal astigmatism measurements in patients with age-related cataract. Participants undergoing preoperative cataract evaluation are classified into a control group or a dry eye disease group according to ocular surface symptoms and objective tear film findings.
All participants undergo ocular surface assessment and repeated corneal measurements using three commonly used devices: IOLMaster 700, Pentacam AXL, and iTrace Prime. Measurements include keratometric corneal astigmatism, total corneal astigmatism, and vector components of astigmatism. Patients with dry eye disease receive 0.3% sodium hyaluronate eye drops four times daily for 2 weeks, after which ocular surface assessment and device measurements are repeated.
The primary objective is to determine whether dry eye disease reduces interdevice agreement and test-retest repeatability of corneal astigmatism measurements, and whether short-term ocular surface treatment improves measurement stability. Interdevice agreement is assessed using Bland-Altman analysis, and repeatability is evaluated using within-subject standard deviation, test-retest repeatability, and intraclass correlation coefficient.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Baoxian Zhuo
- E-post: 1532483480@qq.com
Studer Kontakt Backup
- Navn: Xuanqiao Lin, Doctor
- Telefonnummer: +8615088920668
- E-post: 1532483480@qq.com
Studiesteder
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200000
- Rekruttering
- Eye and ENT Hospital of Fudan University
-
Ta kontakt med:
- Xuanqiao Lin
- Telefonnummer: 15088920668
- E-post: 1532483480@qq.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Patients with age-related cataract undergoing preoperative ocular examination.
- Ability to complete ocular surface evaluation, including the Ocular Surface
- Disease Index questionnaire, non-invasive tear film break-up time, tear meniscus height, Schirmer test, and ocular surface staining.
- Ability to complete repeated corneal astigmatism measurements using IOLMaster 700, Pentacam AXL, and iTrace Prime.
- Ability to maintain stable fixation during device measurements. Provision of written informed consent.
Exclusion Criteria:
- Previous ocular surgery or ocular trauma.
- Corneal degeneration, corneal dystrophy, or other corneal diseases that could affect corneal measurements.
- Active corneal or conjunctival infection.
- Uveitis.
- Use of any topical eye drops within 24 hours before examination.
- Use of antiglaucoma medications.
- Contact lens wear within 1 month before examination.
- Previous or ongoing treatment for dry eye disease.
- Poor fixation during device measurements.
- Poor-quality measurements from any study device
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control Cohort
Patients with age-related cataract who did not meet the diagnostic criteria for dry eye disease.
Participants underwent ocular surface evaluation and repeated corneal astigmatism measurements using IOLMaster 700, Pentacam AXL, and iTrace Prime.
No ocular surface treatment was administered in this cohort.
|
|
|
Eksperimentell: Dry Eye Disease Cohort
Patients with age-related cataract who met the diagnostic criteria for dry eye disease.
Participants underwent baseline ocular surface evaluation and repeated corneal astigmatism measurements using IOLMaster 700, Pentacam AXL, and iTrace Prime.
They then received 0.3% sodium hyaluronate eye drops four times daily for 2 weeks, followed by repeat ocular surface evaluation and device measurements using the same protocol.
|
0.3% sodium hyaluronate eye drops administered four times daily for 2 weeks in participants with dry eye disease.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Interdevice Agreement of Corneal Astigmatism Measurements
Tidsramme: Baseline and 2 weeks after ocular surface treatment in the dry eye disease arm.
|
Interdevice agreement of corneal astigmatism measurements among IOLMaster 700, Pentacam AXL, and iTrace Prime will be assessed using Bland-Altman analysis.
Pairwise comparisons will be performed for IOLMaster 700 versus Pentacam AXL, IOLMaster 700 versus iTrace Prime, and Pentacam AXL versus iTrace Prime.
The main parameters include keratometric corneal astigmatism, total corneal astigmatism, and their vector components J0 and J45.
The mean difference and 95% limits of agreement will be calculated.
|
Baseline and 2 weeks after ocular surface treatment in the dry eye disease arm.
|
|
Test-Retest Repeatability of Corneal Astigmatism Measurements
Tidsramme: Baseline and 2 weeks after ocular surface treatment in the dry eye disease arm.
|
Test-retest repeatability of corneal astigmatism measurements obtained using IOLMaster 700, Pentacam AXL, and iTrace Prime will be evaluated using three consecutive valid measurements from each device.
The main parameters include keratometric corneal astigmatism, total corneal astigmatism, and their vector components J0 and J45.
Repeatability will be assessed using within-subject standard deviation, test-retest repeatability calculated as 2.77 times the within-subject standard deviation, and intraclass correlation coefficient with 95% confidence intervals.
|
Baseline and 2 weeks after ocular surface treatment in the dry eye disease arm.
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studiestol: Xuanqiao Lin, Doctor, Fudan University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- DryEye-2026-001
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .